Get started
Author

Carolien Boeckx

The tale of TILs in breast cancer: A report from The International Immuno-Oncology Biomarker Working Group
2021 · Khalid El Bairi, Harry R. Haynes, et al. · npj Breast Cancer · 286
PDF
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancer
2020 · Zuzana Kos, Elvire Roblin, et al. · npj Breast Cancer · 215
PDF
Report on computational assessment of Tumor Infiltrating Lymphocytes from the International Immuno-Oncology Biomarker Working Group
2020 · Mohamed Amgad, Elisabeth Specht Stovgaard, et al. · npj Breast Cancer · 172
PDF
Anti-Epidermal Growth Factor Receptor Therapy in Head and Neck Squamous Cell Carcinoma: Focus on Potential Molecular Mechanisms of Drug Resistance
2013 · Carolien Boeckx, Marc Baay, et al. · The Oncologist · 111
PDF
Overcoming cetuximab resistance in HNSCC: The role of AURKB and DUSP proteins
2014 · Carolien Boeckx, Ken Op de Beeck, et al. · Cancer Letters · 64
KRAS mutation detection and prognostic potential in sporadic colorectal cancer using high-resolution melting analysis
2010 · V Deschoolmeester, C Boeckx, et al. · British Journal of Cancer · 46
PDF
Validated programmed cell death ligand 1 immunohistochemistry assays (E1L3N and SP 142) reveal similar immune cell staining patterns in melanoma when using the same sensitive detection system
2016 · Kelly A Schats, Emily A Van Vré, et al. · Histopathology · 38
PDF
Mutation analysis of genes in the EGFR pathway in Head and Neck cancer patients: implications for anti-EGFR treatment response
2014 · Carolien Boeckx, Christine Weyn, et al. · BMC Research Notes · 38
PDF
Expression Analysis on Archival Material Revisited
2013 · Christophe Deben, Karen Zwaenepoel, et al. · Diagnostic Molecular Pathology · 34
Optimal Evaluation of Programmed Death Ligand-1 on Tumor Cells Versus Immune Cells Requires Different Detection Methods
2018 · Kelly A. Schats, Emily A. Van Vré, et al. · Archives of Pathology & Laboratory Medicine · 32
Establishment and characterization of cetuximab resistant head and neck squamous cell carcinoma cell lines: focus on the contribution of the AP-1 transcription factor.
2015 · Carolien Boeckx, Lina Blockx, et al. · Europe PMC (PubMed Central) · 30
The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors
2012 · An Wouters, Carolien Boeckx, et al. · Current Pharmaceutical Design · 29
The hypoxic tumor microenvironment and drug resistance against EGFR inhibitors: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines
2015 · Carolien Boeckx, Jolien Van den Bossche, et al. · BMC Research Notes · 26
PDF
Application of a risk-management framework for integration of stromal tumor-infiltrating lymphocytes in clinical trials
2020 · Jan Hudeček, Leonie Voorwerk, et al. · npj Breast Cancer · 20
PDF
Expression Analysis on Archival Material
2011 · Carolien Boeckx, An Wouters, et al. · Diagnostic Molecular Pathology · 18
Mechanisms of Cetuximab Resistance and How to Overcome It
2021 · Ines De Pauw, Carolien Boeckx, et al. · Springer eBooks · 4
PDF
The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors
2012 · An Wouters, Carolien Boeckx, et al. · Current Pharmaceutical Design · 4
Abstract 280: RNA isolation from formalin-fixed paraffin-embedded material: A comparison of five commercially available RNA isolation kits
2011 · Carolien Boeckx, An Wouters, et al. · Cancer Research · 1
Abstract 2122: KRAS mutation detection using high resolution melting analysis and its prognostic value in archival colorectal cancer tissues
2010 · Vanessa Deschoolmeester, Carolien Boeckx, et al. · Cancer Research · 1
Abstract 1030: The intriguing interplay between EGFR inhibitors and the hypoxic microenvironment: preclinical study in cetuximab-sensitive head and neck squamous cell carcinoma cell lines.
2013 · Carolien Boeckx, Jolien Van den Bossche, et al. · Cancer Research
Abstract 5628: Overcoming cetuximab resistance in HNSCC: the role of AURKB and DUSP6.
2013 · Carolien Boeckx, Vanessa Deschoolmeester, et al. · Cancer Research
Abstract 1898: Potential molecular mechanisms of intrinsic resistance to EGFR-targeting monoclonal antibodies in HNSCC
2012 · Carolien Boeckx, Ridha Limame, et al. · Cancer Research
Works count: 22
Citation count: 1,169
H-index: 15
I10-index: 15
Year
Topic
Type